Destiny Wealth Partners, LLC Novartis Ag Transaction History

Destiny Wealth Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$75.55 - $92.52 $6,497 - $7,956	86 Added 39.63%	303 $0
Q2 2022 Jul 15, 2022	BUY	$80.52 - $93.75 $6,039 - $7,031	75 Added 52.82%	217 $18,000
Q3 2021 Oct 28, 2021	BUY	$81.78 - $95.14 $11,612 - $13,509	142 New	142 $12,000
Q1 2021 Apr 22, 2021	SELL	$83.5 - $98.47 $11,857 - $13,982	-142 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$78.07 - $94.43 $11,085 - $13,409	142 New	142 $13,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.